Iron Metabolism Disorders clinical trials
The registry lists 21 studies for Iron Metabolism Disorders across more than 10 countries. 7 are recruiting or about to start. 8 of them are mainly about Iron Metabolism Disorders (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12. Counting its 5 narrower conditions too, such as Anemia, Iron-Deficiency: 1,083 studies, 171 open.
Get an email when these change. Save the Iron Metabolism Disorders studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Swiss Federal Institute of Technology (3) · Hospital Universitari Vall d'Hebron Research Institute (2) · Centre Hospitalier Universitaire de la Réunion (1) · Ramsay Générale de Santé (1) · University Hospital, Bordeaux (1) · Poznan University of Physical Education (1) · Universidad Politecnica de Madrid (1) · Victor Gordeuk (1)
What is being tested here
Drugs under test in Iron Metabolism Disorders studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Erythropoietin | 0 | 0 | 1 |
| Iron isomaltoside 1000 | 0 | 0 | 1 |
| Beta Carotene | 0 | 0 | 1 |
| Deferiprone | 0 | 1 | 1 |
| Deferitazole | 0 | 0 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
Who these studies take
Of the 5 Iron Metabolism Disorders studies recruiting now, 1 (20%) set no upper age limit and 2 (40%) stop at 75 or younger. 2 (40%) take children under 18. 1 (20%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 2 (40%) | 2 (40%) |
| 18 | 5 (100%) | 4 (80%) |
| 30 | 4 (80%) | 3 (60%) |
| 40 | 4 (80%) | 3 (60%) |
| 50 | 3 (60%) | 3 (60%) |
| 65 | 3 (60%) | 3 (60%) |
| 75 | 3 (60%) | 3 (60%) |
| 85 | 3 (60%) | 3 (60%) |
Across all 21 studies, recruiting or not: 57% stop at 75 or younger and 57% at 65; 24% take children; 24% are for women only and 14% for men only; 43% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
What changed recently
From the registry's own updates since Oct 15, 2026.
Newly registered1
- FIA Acute InflammationNov 12, 2026NCT07931937
Studies
Recruiting first, then most recently updated. Showing 21 of 21. search them.
- FIA Acute InflammationNot yet recruitingNCT07931937Not applicable1 country
- Brain Iron in Beta-Propeller Protein Associated Neurodegeneration (BPAN)Not yet recruitingNCT07868120Not applicable1 country
- Hepcidin and Glucose MetabolismRecruitingNCT04008147Not applicable1 country
- Effect of Krill Oil Supplementation on Red Blood Cell Physiology Against Changes in Markers of Iron Metabolism.RecruitingNCT06151548Phase 41 country
- European Rare Blood Disorders Platform (ENROL)RecruitingNCT062505951 country
- RADeep Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs)RecruitingNCT062134021 country
- Study of Markers of Iron Metabolism and Their Relationship With Phosphocalcic and Hepatic Metabolism and Inflammation in Hemodialysis PatientsRecruitingNCT055868671 country
- Effects of Intermittent Hypoxia Training With Iron Supplementation on Red Blood Cells and Iron Levels in Trained AthletesCompletedNCT07720960Not applicable1 country
- Effects of Intravenous Injection of Erythropoietin on Hepcidin Pharmacokinetics in Healthy VolunteersCompletedNCT00687518Not applicable1 country
- Supplementation With Altha-aminoacids and Systemiec Inflammatory Response in Long-distance Runners.Status unknownNCT05510440Not applicable1 country
- Treatment of Iron Overload Requiring Chelation TherapyWithdrawnNCT01927913Phase 2
- Inhibiting Dietary Iron Absorption in Subjects With Hereditary Hemochromatosis by a Natural Polyphenol SupplementCompletedNCT03990181Not applicable2 countries
- Iron and Muscular Damage: FEmale Metabolism and Menstrual Cycle During ExerciseCompletedNCT044586621 country
- The Effect of Genetic Variation in TMPRSS6 Gene (SNP rs855791) on Oral Iron Absorption: an Iron Stable Isotope StudyCompletedNCT03317873Not applicable1 country
- Influence of Umbilical Cord Clamping Time in the NewbornCompletedNCT03624335Not applicable1 country
- Association of Serum Ferritin and Bone Mineral Density With Bone Metabolism in Chinese Healthy Postmenopausal WomenStatus unknownNCT035127431 country
- Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®)CompletedNCT03013439Phase 11 country
- Iron Status in Women of Reproductive Age Reproductive AgeCompletedNCT032762471 country
- Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone and Incretin Based TherapyStatus unknownNCT02882477Phase 2/31 country
- Metabolic Disorders in Ultramarathon Runners During and After the Reunion Island Madmen's DiagonalCompletedNCT02275429Not applicable1 country
- Low Dose β-carotene Supplementation Diminishes Oxidative Stress in Type 2 Diabetics and Healthy IndividualsCompletedNCT01477112Not applicable1 country